No amendment in the last 12 months on an offering that may still be open — Comera Life Sciences Holdings, Inc. (latest filing Aug 7, 2023)
The latest filing for this offering is dated Aug 7, 2023 (first sale Jul 31, 2023). It reports $2,249,000 sold of $4,070,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
Sources
- Form D · Aug 7, 2023 ↗ (Aug 7, 2023)
- Comera Life Sciences Holdings, Inc. — PartnerFacts page ↗ (Jan 8, 2024)